VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 94 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $41,311 | -39.3% | 331,287 | -49.9% | 0.00% | – |
| Q4 2022 | $68,081 | -47.2% | 660,977 | -21.9% | 0.00% | – |
| Q3 2022 | $129,000 | +174.5% | 846,098 | +1486.0% | 0.00% | – |
| Q2 2022 | $47,000 | -90.2% | 53,349 | -86.2% | 0.00% | -100.0% |
| Q1 2022 | $479,000 | -47.9% | 386,602 | -18.0% | 0.00% | -50.0% |
| Q4 2021 | $920,000 | -70.0% | 471,709 | -57.8% | 0.00% | -71.4% |
| Q3 2021 | $3,065,000 | -18.2% | 1,118,684 | -5.9% | 0.01% | -12.5% |
| Q2 2021 | $3,746,000 | +87.5% | 1,189,121 | +26.8% | 0.01% | +60.0% |
| Q1 2021 | $1,998,000 | +626.5% | 937,956 | +562.9% | 0.01% | +400.0% |
| Q4 2020 | $275,000 | +2015.4% | 141,498 | +640.9% | 0.00% | – |
| Q3 2020 | $13,000 | – | 19,098 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,736,283 | $14,553,000 | 6.80% |
| VR Adviser, LLC | 16,047,286 | $19,899,000 | 3.22% |
| COMMODORE CAPITAL LP | 10,097,229 | $12,521,000 | 2.80% |
| SPHERA FUNDS MANAGEMENT LTD. | 4,951,423 | $6,140,000 | 0.87% |
| EPIQ PARTNERS, LLC | 1,161,350 | $1,440,000 | 0.77% |
| NEA Management Company, LLC | 16,302,596 | $20,215,000 | 0.58% |
| Nicholas Investment Partners, LP | 4,570,387 | $5,667,000 | 0.40% |
| Ghost Tree Capital, LLC | 1,315,154 | $1,631,000 | 0.35% |
| Orbimed Advisors | 12,909,283 | $16,008,000 | 0.26% |
| HighVista Strategies LLC | 315,880 | $392,000 | 0.25% |